Radiation-Induced Biological Effects: Molecular and Cellular Mechanism, and Applications to Radiation/Nuclear Emergency and Cancer Therapy

Abstract

Radiation has been wildly used in clinics for disease therapy over a century. However, the side effects associated with radiotherapy are often substantial and multifaceted, underscoring the need for effective management of radiation-induced injuries. Additionally, with the growing reliance on nuclear technology, concerns about accidental exposures have intensified. Radiation-induced biological effects represent a highly complex process that impacts multiple physiological activities within organisms. Ongoing research aims to elucidate the underlying molecular mechanisms and to develop reliable methods for radiation dose estimation—both for emergency scenarios and therapeutic applications. This review provides a systematic overview of the biological effects of ionizing radiation, covering DNA damage and repair pathways, cellular senescence, and diverse modes of cell death. It also offers an in-depth analysis of recent advances in radiation biodosimetry and the application of radiation in cancer therapy, along with insights into future research directions. By integrating mechanistic knowledge with practical applications, this review aims to support the optimization of radiation-based strategies, enhance public health preparedness, and inspire continued innovation in the field.

Keywords

biodosimetry / inflammation / radiation-induced cell death / radiation injury / radiotherapy / senescence

References

[1] S. Saini and P. Gurung, “A Comprehensive Review of Sensors of Radiation-Induced Damage, Radiation-Induced Proximal Events, and Cell Death,” Immunological Reviews 329, no. 1 (2025): e13409.

[2] O. Molinar-Inglis, A. L. DiCarlo, P. J. Lapinskas, et al., “Radiation-Induced Multi-Organ Injury,” International Journal of Radiation Biology 100, no. 3 (2024): 486–504.

[3] C. Forenzo and J. Larsen, “Bridging Clinical Radiotherapy and Space Radiation Therapeutics Through Reactive Oxygen Species (ROS)-Triggered Delivery,” Free Radical Biology and Medicine 219 (2024): 88–103.

[4] J. A. Reisz, N. Bansal, J. Qian, W. Zhao, and C. M. Furdui, “Effects of Ionizing Radiation on Biological Molecules–Mechanisms of Damage and Emerging Methods of Detection,” Antioxidants & Redox Signaling 21, no. 2 (2014): 260–292.

[5] C. A. Montesinos, R. Khalid, O. Cristea, et al., “Space Radiation Protection Countermeasures in Microgravity and Planetary Exploration,” Life (Basel) 11, no. 8 (2021): 829.

[6] B. A. Ulsh, “Are Risks from Medical Imaging Still Too Small to Be Observed or Nonexistent?,” Dose Response 13, no. 1 (2015): dose–response.14–030.Ulsh.

[7] A. Haimovitz-Friedman, A. Mizrachi, and E. A. Jaimes, “Manipulating Oxidative Stress Following Ionizing Radiation,” Journal of Cellular Signaling 1, no. 1 (2020): 8–13.

[8] J. Talapko, D. Talapko, D. Katalinić, et al., “Health Effects of Ionizing Radiation on the Human Body,” Medicina (Kaunas, Lithuania) 60, no. 4 (2024): 653.

[9] Y. Jiao, F. Cao, and H. Liu, “Radiation-Induced Cell Death and Its Mechanisms,” Health Physics 123, no. 5 (2022): 376–386.

[10] E. A. Ainsbury, E. Bakhanova, J. F. Barquinero, et al., “Review of Retrospective Dosimetry Techniques for External Ionising Radiation Exposures,” Radiation Protection Dosimetry 147, no. 4 (2011): 573–592.

[11] V. A. Vinnikov, E. A. Ainsbury, N. A. Maznyk, D. C. Lloyd, and K. Rothkamm, “Limitations Associated With Analysis of Cytogenetic Data for Biological Dosimetry,” Radiation Research 174, no. 4 (2010): 403–414.

[12] B. Tomasik, W. Fendler, and D. Chowdhury, “Serum microRNAs—Potent Biomarkers for Radiation Biodosimetry,” Oncotarget 9, no. 18 (2018): 14038–14039.

[13] M. E. Lomax, L. K. Folkes, and P. O'Neill, “Biological Consequences of Radiation-Induced DNA Damage: Relevance to Radiotherapy,” Clinical Oncology (Royal College of Radiologists (Great Britain)) 25, no. 10 (2013): 578–585.

[14] S. Zhao, S. L. Habib, A. G. Senejani, M. Sebastian, and D. Kidane, “Role of Base Excision Repair in Innate Immune Cells and Its Relevance for Cancer Therapy,” Biomedicines 10, no. 3 (2022): 557.

[15] G. J. Grundy and J. L. Parsons, “Base Excision Repair and Its Implications to Cancer Therapy,” Essays in Biochemistry 64, no. 5 (2020): 831–843.

[16] I. Venkata Narayanan, M. T. Paulsen, K. Bedi, et al., “Transcriptional and Post-Transcriptional Regulation of the Ionizing Radiation Response by ATM and P53,” Scientific Reports 7 (2017): 43598.

[17] Y. Tian, T. Feng, J. Zhang, et al., “Histone H1 Deamidation Facilitates Chromatin Relaxation for DNA Repair,” Nature 641, no. 8063 (2025): 779–787.

[18] H. Lu, J. Guan, S. Y. Wang, G. M. Li, V. A. Bohr, and A. J. Davis, “DNA-PKcs-Dependent Phosphorylation of RECQL4 Promotes NHEJ by Stabilizing the NHEJ Machinery at DNA Double-Strand Breaks,” Nucleic Acids Research 50 (2022): 5635–5651.

[19] S. J. Bright, D. B. Flint, B. X. Turner, et al., “Inhibiting ATR Modulates Response to Radiation and Stimulates Immune Responses,” International Journal of Radiation Oncology*Biology*Physics 111, no. S3 (2021): S69–S70.

[20] Y. Qi, J. W. Warmenhoven, N. T. Henthorn, et al., “Mechanistic Modelling of Slow and Fast NHEJ DNA Repair Pathways Following Radiation for G0/G1 Normal Tissue Cells,” Cancers (Basel) 13, no. 9 (2021): 2202.

[21] Z. Chen, H. Wakabayashi, R. Kuroda, et al., “Radiation Exposure Lymphocyte Damage Assessed by γ-H2AX Level Using Flow Cytometry,” Scientific Reports 14, no. 1 (2024): 4339.

[22] A. Soni, E. Mladenov, and G. Iliakis, “Proficiency in Homologous Recombination Repair Is Prerequisite for Activation of G2-Checkpoint at Low Radiation Doses,” DNA Repair 101 (2021): 103076.

[23] O. Belov, A. Chigasova, M. Pustovalova, et al., “Dose-Dependent Shift in Relative Contribution of Homologous Recombination to DNA Repair After Low-LET Ionizing Radiation Exposure: Empirical Evidence and Numerical Simulation,” Current Issues in Molecular Biology 45, no. 9 (2023): 7352–7373.

[24] Q. Wu, X. Leng, Q. Zhang, et al., “IRF3 Activates RB to Authorize cGAS-STING-Induced Senescence and Mitigate Liver Fibrosis,” Science Advances 10, no. 9 (2024): eadj2102.

[25] D. Muñoz-Espín, M. Cañamero, A. Maraver, et al., “Programmed Cell Senescence During Mammalian Embryonic Development,” Cell 155, no. 5 (2013): 1104–1118.

[26] A. Zingoni, F. Antonangeli, S. Sozzani, A. Santoni, M. Cippitelli, and A. Soriani, “The Senescence Journey in Cancer Immunoediting,” Molecular Cancer 23, no. 1 (2024): 68.

[27] N. Dehghan, S. N. Mousavikia, Y. Qasempour, and H. Azimian, “Radiation-Induced Senescence in Glioblastoma: An Overview of the Mechanisms and Eradication Strategies,” Life Sciences 359 (2024): 123218.

[28] M. Ibragimova, A. Kussainova, A. Aripova, R. Bersimbaev, and O. Bulgakova, “The Molecular Mechanisms in Senescent Cells Induced by Natural Aging and Ionizing Radiation,” Cells 13, no. 6 (2024): 550.

[29] S. G. Rao and J. G. Jackson, “SASP: Tumor Suppressor or Promoter? Yes!,” Trends in Cancer 2, no. 11 (2016): 676–687.

[30] M. Takasugi, Y. Yoshida, E. Hara, and N. Ohtani, “The Role of Cellular Senescence and SASP in Tumour Microenvironment,” Febs Journal 290, no. 5 (2023): 1348–1361.

[31] Y. Wang, B. A. Schulte, A. C. LaRue, M. Ogawa, and D. Zhou, “Total Body Irradiation Selectively Induces Murine Hematopoietic Stem Cell Senescence,” Blood 107, no. 1 (2006): 358–366.

[32] Y. Wang, M. Boerma, and D. Zhou, “Ionizing Radiation-Induced Endothelial Cell Senescence and Cardiovascular Diseases,” Radiation Research 186, no. 2 (2016): 153–161.

[33] L. Zhang, L. Cai, Y. Cai, et al., “Studies on the Role of Moderate Doses of Ionizing Radiation-Induced Cellular Senescence in Mouse Lung Tissue,” International Journal of Radiation Biology 100, no. 12 (2024): 1650–1664.

[34] Z. Cheng, Y. Z. Zheng, Y. Q. Li, and C. S. Wong, “Cellular Senescence in Mouse Hippocampus after Irradiation and the Role of P53 and P21,” Journal of Neuropathology and Experimental Neurology 76, no. 4 (2017): 260–269.

[35] L. Li, T. Zhang, M. Xiao, Y. Lu, and L. Gao, “Brain Macrophage Senescence in Glioma,” Seminars in Cancer Biology 104-105 (2024): 46–60.

[36] Y. Chen, L. Ma, Z. Cheng, et al., “Senescent Fibroblast Facilitates Re-Epithelization and Collagen Deposition in Radiation-Induced Skin Injury Through IL-33-Mediated Macrophage Polarization,” Journal of Translational Medicine 22, no. 1 (2024): 176.

[37] H. Zhou, C. Li, Y. Ren, et al., “Modulation of Epithelial-Mesenchymal Transition by Gemcitabine: Targeting Ionizing Radiation-Induced Cellular Senescence in Lung Cancer Cell,” Biochemical Pharmacology 224 (2024): 116234.

[38] C. Turnquist, J. A. Beck, I. Horikawa, et al., “Radiation-Induced Astrocyte Senescence Is Rescued by Δ133p53,” Neuro-Oncology 21, no. 4 (2019): 474–485.

[39] E. Fletcher-Sananikone, S. Kanji, N. Tomimatsu, et al., “Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence,” Cancer Research 81, no. 23 (2021): 5935–5947.

[40] N. Tomimatsu, L. F. M. Di Cristofaro, S. Kanji, et al., “Targeting cIAP2 in a Novel Senolytic Strategy Prevents Glioblastoma Recurrence After Radiotherapy,” EMBO Molecular Medicine 17, no. 4 (2025): 645–678.

[41] B. Ritschka, M. Storer, A. Mas, et al., “The Senescence-Associated Secretory Phenotype Induces Cellular Plasticity and Tissue Regeneration,” Genes & Development 31, no. 2 (2017): 172–183.

[42] J. F. Kerr, A. H. Wyllie, and A. R. Currie, “Apoptosis: A Basic Biological Phenomenon With Wide-Ranging Implications in Tissue Kinetics,” British Journal of Cancer 26, no. 4 (1972): 239–257.

[43] R. C. Taylor, S. P. Cullen, and S. J. Martin, “Apoptosis: Controlled Demolition at the Cellular Level,” Nature Reviews Molecular Cell Biology 9, no. 3 (2008): 231–241.

[44] R. N. Kolesnick, A. Haimovitz-Friedman, and Z. Fuks, “The Sphingomyelin Signal Transduction Pathway Mediates Apoptosis for Tumor Necrosis Factor, Fas, and Ionizing Radiation,” Biochemistry and Cell Biology 72, no. 11–12 (1994): 471–474.

[45] A. Haimovitz-Friedman, C. C. Kan, D. Ehleiter, et al., “Ionizing Radiation Acts on Cellular Membranes to Generate Ceramide and Initiate Apoptosis,” Journal of Experimental Medicine 180, no. 2 (1994): 525–535.

[46] J. Rotolo, B. Stancevic, J. Zhang, et al., “Anti-Ceramide Antibody Prevents the Radiation Gastrointestinal Syndrome in Mice,” Journal of Clinical Investigation 122, no. 5 (2012): 1786–1790.

[47] J. A. Rotolo, C. S. Fong, S. Bodo, et al., “Anti-Ceramide Single-Chain Variable Fragment Mitigates Radiation GI Syndrome Mortality Independent of DNA Repair,” JCI Insight 6, no. 8 (2021): e145380.

[48] P. Santana, L. A. Peña, A. Haimovitz-Friedman, et al., “Acid Sphingomyelinase-Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis,” Cell 86, no. 2 (1996): 189–199.

[49] J. D. Amaral, J. M. Xavier, C. J. Steer, and C. M. Rodrigues, “The Role of P53 in Apoptosis,” Discovery Medicine 9, no. 45 (2010): 145–152.

[50] A. V. Gudkov and E. A. Komarova, “Pathologies Associated With the P53 Response,” Cold Spring Harbor Perspectives in Biology 2 (2010): a001180.

[51] J. A. Rotolo, J. G. Maj, R. Feldman, et al., “Bax and Bak Do Not Exhibit Functional Redundancy in Mediating Radiation-Induced Endothelial Apoptosis in the Intestinal Mucosa,” International Journal of Radiation and Oncology in Biology and Physics 70, no. 3 (2008): 804–815.

[52] K. Li, Y. Li, J. M. Shelton, et al., “Cytochrome c Deficiency Causes Embryonic Lethality and Attenuates Stress-Induced Apoptosis,” Cell 101, no. 4 (2000): 389–399.

[53] J. Atkinson, A. A. Kapralov, N. Yanamala, et al., “A Mitochondria-Targeted Inhibitor of Cytochrome c Peroxidase Mitigates Radiation-Induced Death,” Nature Communications 2 (2011): 497.

[54] T. Shimura, “Mitochondrial Signaling Pathways Associated With DNA Damage Responses,” International Journal of Molecular Sciences 24, no. 7 (2023): 6128.

[55] S. Fulda, C. Scaffidi, T. Pietsch, P. H. Krammer, M. E. Peter, and K. M. Debatin, “Activation of the CD95 (APO-1/Fas) Pathway in Drug- and Gamma-Irradiation-Induced Apoptosis of Brain Tumor Cells,” Cell Death and Differentiation 5, no. 10 (1998): 884–893.

[56] X. Cao, P. Wen, Y. Fu, et al., “Radiation Induces Apoptosis Primarily Through the Intrinsic Pathway in Mammalian Cells,” Cellular Signalling 62 (2019): 109337.

[57] X. Jiang, B. R. Stockwell, and M. Conrad, “Ferroptosis: Mechanisms, Biology and Role in Disease,” Nature Reviews Molecular Cell Biology 22, no. 4 (2021): 266–282.

[58] D. Tang, X. Chen, R. Kang, and G. Kroemer, “Ferroptosis: Molecular Mechanisms and Health Implications,” Cell Research 31, no. 2 (2021): 107–125.

[59] F. Zeng, S. Nijiati, L. Tang, J. Ye, Z. Zhou, and X. Chen, “Ferroptosis Detection: From Approaches to Applications,” Angewandte Chemie (International Ed in English) 62, no. 35 (2023): e202300379.

[60] D. Liang, A. M. Minikes, and X. Jiang, “Ferroptosis at the Intersection of Lipid Metabolism and Cellular Signaling,” Molecular Cell 82, no. 12 (2022): 2215–2227.

[61] S. Ramos, E. Hartenian, J. C. Santos, P. Walch, and P. Broz, “NINJ1 Induces Plasma Membrane Rupture and Release of Damage-Associated Molecular Pattern Molecules During Ferroptosis,” EMBO Journal 43, no. 7 (2024): 1164–1186.

[62] A. W. Konings, J. Damen, and W. B. Trieling, “Protection of Liposomal Lipids Against Radiation Induced Oxidative Damage,” International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine 35, no. 4 (1979): 343–350.

[63] S. Zhang, J. Zhang, X. Fan, et al., “Ionizing Radiation-Induced Ferroptosis Based on Nanomaterials,” International Journal of Nanomedicine 17 (2022): 3497–3507.

[64] P. Yang, J. Li, T. Zhang, et al., “Ionizing Radiation-Induced Mitophagy Promotes Ferroptosis by Increasing Intracellular Free Fatty Acids,” Cell Death and Differentiation 30, no. 11 (2023): 2432–2445.

[65] S. R. Zwart, J. L. L. Morgan, and S. M. Smith, “Iron Status and Its Relations With Oxidative Damage and Bone Loss During Long-Duration Space Flight on the International Space Station,” American Journal of Clinical Nutrition 98, no. 1 (2013): 217–223.

[66] P. Koppula, L. Zhuang, and B. Gan, “Cystine Transporter SLC7A11/xCT in Cancer: Ferroptosis, Nutrient Dependency, and Cancer Therapy,” Protein Cell 12, no. 8 (2021): 599–620.

[67] H. Zhou, Y. L. Zhou, J. A. Mao, et al., “NCOA4-Mediated Ferritinophagy Is Involved in Ionizing Radiation-Induced Ferroptosis of Intestinal Epithelial Cells,” Redox Biology 55 (2022): 102413.

[68] X. Zhang, X. Xing, H. Liu, et al., “Ionizing Radiation Induces Ferroptosis in Granulocyte-Macrophage Hematopoietic Progenitor Cells of Murine Bone Marrow,” International Journal of Radiation Biology 96, no. 5 (2020): 584–595.

[69] P. H. Chen, J. Wu, C. K. C. Ding, et al., “Kinome Screen of Ferroptosis Reveals a Novel Role of ATM in Regulating Iron Metabolism,” Cell Death and Differentiation 27, no. 3 (2020): 1008–1022.

[70] C. Huang, Y. Guo, T. Li, et al., “Pharmacological Activation of GPX4 Ameliorates Doxorubicin-Induced Cardiomyopathy,” Redox Biology 70 (2024): 103024.

[71] N. Lorito, A. Subbiani, A. Smiriglia, et al., “FADS1/2 Control Lipid Metabolism and Ferroptosis Susceptibility in Triple-Negative Breast Cancer,” EMBO Molecular Medicine 16, no. 7 (2024): 1533–1559.

[72] J. Cui, Y. Chen, Q. Yang, et al., “Protosappanin A Protects DOX-Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis-Dependent Ferroptosis,” Advanced Science 11, no. 34 (2024): e2310227.

[73] Q. Ji, S. Fu, H. Zuo, et al., “ACSL4 Is Essential for Radiation-Induced Intestinal Injury by Initiating Ferroptosis,” Cell Death Discovery 8, no. 1 (2022): 332.

[74] G. Lei, A. Horbath, Z. Li, and B. Gan, “PKCβII-ACSL4 Pathway Mediating Ferroptosis Execution and Anti-Tumor Immunity,” Cancer Commun (Lond) 42, no. 7 (2022): 583–586.

[75] F. Yang, Y. Xiao, J. H. Ding, et al., “Ferroptosis Heterogeneity in Triple-Negative Breast Cancer Reveals an Innovative Immunotherapy Combination Strategy,” Cell Metabolism 35, no. 1 (2023): 84–100.

[76] L. J. Yant, Q. Ran, L. Rao, et al., “The Selenoprotein GPX4 Is Essential for Mouse Development and Protects From Radiation and Oxidative Damage Insults,” Free Radical Biology and Medicine 34, no. 4 (2003): 496–502.

[77] J. Ning, L. Chen, Y. Zeng, et al., “The Scheme, and Regulative Mechanism of Pyroptosis, Ferroptosis, and Necroptosis in Radiation Injury,” International Journal of Biological Sciences 20, no. 5 (2024).

[78] A. Degterev, Z. Huang, M. Boyce, et al., “Chemical Inhibitor of Nonapoptotic Cell Death With Therapeutic Potential for Ischemic Brain Injury,” Nature Chemical Biology 1, no. 2 (2005): 112–119.

[79] X. Liu, X. Xie, Y. Ren, et al., “The Role of Necroptosis in Disease and Treatment,” MedComm 2, no. 4 (2021): 730–755.

[80] M. A. Nehs, C. I. Lin, D. E. Kozono, et al., “Necroptosis Is a Novel Mechanism of Radiation-Induced Cell Death in Anaplastic Thyroid and Adrenocortical Cancers,” Surgery 150, no. 6 (2011): 1032–1039.

[81] S. E. El Feky, K. A. Fakhry, A. M. Hussain, F. A. R. Ibrahim, and M. I. Morsi, “MLKL Regulates Radiation-Induced Death in Breast Cancer Cells: An Interplay Between Apoptotic and Necroptotic Signals,” Medical Oncology 41, no. 7 (2024): 172.

[82] Y. Xu, W. Tu, D. Sun, et al., “Nrf2 Alleviates Radiation-Induced Rectal Injury by Inhibiting of Necroptosis,” Biochemical and Biophysical Research Communications 554 (2021): 49–55.

[83] Z. Huang, M. Epperly, S. C. Watkins, J. S. Greenberger, V. E. Kagan, and H. Bayır, “Necrostatin-1 Rescues Mice From Lethal Irradiation,” Biochimica Et Biophysica Acta 1862, no. 4 (2016).

[84] K. D. Castle, A. R. Daniel, E. J. Moding, L. Luo, C. L. Lee, and D. G. Kirsch, “Mice Lacking RIP3 Kinase Are Not Protected From Acute Radiation Syndrome,” Rare 189, no. 6 (2018): 627–633.

[85] K. Schroder and J. Tschopp, “The Inflammasomes,” Cell 140, no. 6 (2010): 821–832.

[86] Z. Zhang, J. Zhou, V. Verma, et al., “Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury,” Frontiers in Immunology 12 (2021): 774807.

[87] V. M. Stoecklein, A. Osuka, S. Ishikawa, M. R. Lederer, L. Wanke-Jellinek, and J. A. Lederer, “Radiation Exposure Induces Inflammasome Pathway Activation in Immune Cells,” Journal of Immunology 194, no. 3 (2015): 1178–1189.

[88] B. Hu, C. Jin, H. B. Li, et al., “The DNA-Sensing AIM2 Inflammasome Controls Radiation-Induced Cell Death and Tissue Injury,” Science 354, no. 6313 (2016): 765–768.

[89] W. J. Brickey, M. A. Thompson, Z. Sheng, Z. Li, K. Owzar, and J. P. Y. Ting, “Re-Examination of the Exacerbating Effect of Inflammasome Components During Radiation Injury,” Radiation Research 197, no. 2 (2022): 199–204.

[90] V. Palivec, E. Pluhařová, I. Unger, B. Winter, and P. Jungwirth, “DNA Lesion Can Facilitate Base Ionization: Vertical Ionization Energies of Aqueous 8-Oxoguanine and Its Nucleoside and Nucleotide,” Journal of Physical Chemistry B 118, no. 48 (2014): 13833–13837.

[91] Y. Wang, Y. Zhang, C. Huang, Q. Fu, and T. Huang, “Impact of Ultra-High-Dose-Rate Irradiation on DNA: Single-Strand Breaks and Base Damage,” International Journal of Molecular Sciences 26, no. 5 (2025): 1800.

[92] M. Svetlova, L. Solovjeva, A. Kropotov, and A. Nikiforov, “The Impact of NAD Bioavailability on DNA Double-Strand Break Repair Capacity in Human Dermal Fibroblasts After Ionizing Radiation,” Cells 12, no. 11 (2023): 1518.

[93] J. Ameixa and I. Bald, “Unraveling the Complexity of DNA Radiation Damage Using DNA Nanotechnology,” Accounts of Chemical Research 57, no. 11 (2024): 1608–1619.

[94] H. Ikehata and M. Yamamoto, “Roles of the KEAP1-NRF2 System in Mammalian Skin Exposed to UV Radiation,” Toxicology and Applied Pharmacology 360 (2018): 69–77.

[95] Y. Zhu, W. Zuo, X. Shen, et al., “NF-κB Is Involved in the Regulation of Autophagy in Mutant P53 Cells in Response to Ionizing Radiation,” Cell Death Discovery 7, no. 1 (2021): 159.

[96] Z. Tong, W. Fang, M. Xu, et al., “DAB2IP Predicts Treatment Response and Prognosis of ESCC Patients and Modulates Its Radiosensitivity Through Enhancing IR-Induced Activation of the ASK1-JNK Pathway,” Cancer Cell International 22, no. 1 (2022): 106.

[97] Z. Liu, J. Jiang, Q. He, et al., “β-Arrestin1-Mediated Decrease in Endoplasmic Reticulum Stress Impairs Intestinal Stem Cell Proliferation Following Radiation,” Faseb Journal 33, no. 9 (2019): 10165–10176.

[98] M. Zhang, H. Lan, M. Jiang, et al., “NLRP3 Inflammasome Mediates Pyroptosis of Alveolar Macrophages to Induce Radiation Lung Injury,” Journal of Hazardous Materials 484 (2025): 136740.

[99] C. J. Perez-Torres, J. A. Engelbach, J. Cates, et al., “Toward Distinguishing Recurrent Tumor From Radiation Necrosis: DWI and MTC in a Gamma Knife–Irradiated Mouse Glioma Model,” International Journal of Radiation and Oncology in Biology and Physics 90, no. 2 (2014): 446–453.

[100] S. Yamaga, M. Aziz, A. Murao, M. Brenner, and P. Wang, “DAMPs and Radiation Injury,” Frontiers in Immunology 15 (2024): 1353990.

[101] C. S. Spina and C. G. Drake, “Mechanisms of Immune Modulation by Radiation,” Seminars in Radiation Oncology 31, no. 3 (2021): 205–216.

[102] K. J. McKelvey, A. L. Hudson, M. Back, T. Eade, and C. I. Diakos, “Radiation, Inflammation and the Immune Response in Cancer,” Mammalian Genome 29, no. 11 (2018): 843–865.

[103] S. Dai, Y. Wen, P. Luo, et al., “Therapeutic Implications of Exosomes in the Treatment of Radiation Injury,” Burns & Trauma 10 (2022): tkab043.

[104] C. Mothersill, C. Seymour, A. Cocchetto, and D. Williams, “Factors Influencing Effects of Low-Dose Radiation Exposure,” Health Physics 126, no. 5 (2024): 296.

[105] J. Zhang, K. Dai, R. An, et al., “Single Low-Dose Ionizing Radiation Transiently Enhances Rat RIN-m5F Cell Function via the ROS/P38 MAPK Pathway Without Inducing Cell Damage,” Antioxidants (Basel) 14, no. 2 (2025): 120.

[106] S. J. Dixon, K. M. Lemberg, M. R. Lamprecht, et al., “Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death,” Cell 149, no. 5 (2012): 1060–1072.

[107] X. Zhang, X. Li, C. Zheng, et al., “Ferroptosis, a New Form of Cell Death Defined After Radiation Exposure,” International Journal of Radiation Biology 98, no. 7 (2022): 1201–1209.

[108] I. P. Edimecheva, M. A. Kisel, O. I. Shadyro, A. P. Vlasov, and I. L. Yurkova, “The Damage to Phospholipids Caused by Free Radical Attack on Glycerol and Sphingosine Backbone,” International Journal of Radiation Biology 71, no. 5 (1997): 555–560.

[109] D. Einor, A. Bonisoli-Alquati, D. Costantini, T. A. Mousseau, and A. P. Møller, “Ionizing Radiation, Antioxidant Response and Oxidative Damage: A Meta-Analysis,” Science of the Total Environment 548–549 (2016): 463–471.

[110] L. Chen, J. Lai, S. Dong, W. Liu, X. Zhang, and H. Yang, “Mitochondria-Targeted DNA-Based Nanoprobe for In Situ Monitoring of the Activity of the mtDNA Repair Enzyme and Evaluating Tumor Radiosensitivity,” Analytical Chemistry 97, no. 1 (2025): 382–391.

[111] H. Guan, W. Zhang, D. Xie, et al., “Cytosolic Release of Mitochondrial DNA and Associated cGAS Signaling Mediates Radiation-Induced Hematopoietic Injury of Mice,” International Journal of Molecular Sciences 24, no. 4 (2023): 4020.

[112] S. Guo, Y. Yao, Y. Tang, et al., “Radiation-Induced Tumor Immune Microenvironments and Potential Targets for Combination Therapy,” Signal Transduction and Targeted Therapy 8, no. 1 (2023), https://doi.org/10.1038/s41392-023-01462-z.

[113] J. Prakash and Y. Shaked, “The Interplay Between Extracellular Matrix Remodeling and Cancer Therapeutics,” Cancer Discovery 14, no. 8 (2024): 1375–1388.

[114] F. Zhang, Y. Ma, D. Li, et al., “Cancer Associated Fibroblasts and Metabolic Reprogramming: Unraveling the Intricate Crosstalk in Tumor Evolution,” Journal of Hematology & Oncology 17, no. 1 (2024): 80.

[115] S. Liu, W. Wang, S. Hu, et al., “Radiotherapy Remodels the Tumor Microenvironment for Enhancing Immunotherapeutic Sensitivity,” Cell Death & Disease 14, no. 10 (2023): 679.

[116] H. M. Swartz and A. B. Flood, “Rethinking the Role of Biodosimetry to Assess Risks for Acute Radiation Syndrome in Very Large Radiation Events: Reconsidering Legacy Concepts,” Radiation Research 201, no. 5 (2024): 440–448.

[117] S. K. Shakyawar, N. K. Mishra, N. N. Vellichirammal, et al., “A Review of Radiation-Induced Alterations of Multi-omic Profiles, Radiation Injury Biomarkers, and Countermeasures,” Radiation Research 199, no. 1 (2023): 89–111.

[118] B. R. Buddemeier and M. B. Dillon, Key Response Planning Factors for the Aftermath of Nuclear Terrorism (U.S. Department of Energy by Lawrence Livermore National Laboratory, 2009).

[119] N. Dainiak and J. Albanese, “Medical Management of Acute Radiation Syndrome,” Journal of Radiological Protection 42, no. 3 (2022).

[120] I. Macià, M. Garau, A. Lucas Calduch, and E. C. López, “Radiobiology of the Acute Radiation Syndrome,” Reports of Practical Oncology and Radiotherapy 16, no. 4 (2011): 123–130.

[121] P. Arnautou, G. Garnier, J. Maillot, et al., “Management of Acute Radiation Syndrome,” Transfusion Clinique Et Biologique 31, (2024): 253–259.

[122] A. I. Vorobiev, “Acute Radiation Disease and Biological Dosimetry in 1993,” Stem Cells 15, no. S2 (1997): 269–274.

[123] L. Loge, C. Florescu, A. Alves, and B. Menahem, “Radiation Enteritis: Diagnostic and Therapeutic Issues,” Journal of Visceral Surgery 157, no. 6 (2020): 475–485.

[124] Q. Wang, C. Xie, S. Xi, et al., “Radioprotective Effect of Flavonoids on Ionizing Radiation-Induced Brain Damage,” Molecules (Basel, Switzerland) 25, no. 23 (2020): 5719.

[125] C. Zhang, J. Zheng, W. Chen, et al., “Mitochondrial-Targeting Fluorescent Small Molecule IR-780 Alleviates Radiation-Induced Brain Injury,” Brain Research 1805 (2023): 148285.

[126] H. Dörr and V. Meineke, “Acute Radiation Syndrome Caused by Accidental Radiation Exposure—Therapeutic Principles,” BMC Medicine 9 (2011): 126.

[127] B. A. Christy, M. C. Herzig, X. Wu, A. Mohammadipoor, J. S. McDaniel, and J. A. Bynum, “Cell Therapies for Acute Radiation Syndrome,” International Journal of Molecular Sciences 25, no. 13 (2024): 6973.

[128] L. Nemzow, T. Boehringer, B. Bacon, and H. C. Turner, “Development of a Human Peripheral Blood Ex Vivo Model for Rapid Protein Biomarker Detection and Applications to Radiation Biodosimetry,” PLoS ONE 18, no. 8 (2023): e0289634.

[129] M. Pujol-Canadell, E. Young, and L. Smilenov, “Use of a Humanized Mouse Model System in the Validation of Human Radiation Biodosimetry Standards,” Radiation Research 191, no. 5 (2019): 439–446.

[130] M. M. Satyamitra, Z. Perez-Horta, A. L. DiCarlo, et al., “NIH Policies and Regulatory Pathways to U.S. FDA Licensure: Strategies to Inform Advancement of Radiation Medical Countermeasures and Biodosimetry Devices,” Radiation Research 197, no. 5 (2022): 533–553.

[131] S. K. Jeong, S. J. Oh, S. H. Kim, et al., “Dicentric Chromosome Assay Using a Deep Learning-Based Automated System,” Scientific Reports 12, no. 1 (2022): 22097.

[132] A. O. Langlands, P. G. Smith, K. E. Buckton, G. E. Woodcock, and J. McLelland, “Chromosome Damage Induced by Radiation,” Nature 218, no. 5147 (1968): 1133–1135.

[133] E. Royba, M. Repin, A. S. Balajee, et al., “Validation of a High-Throughput Dicentric Chromosome Assay Using Complex Radiation Exposures,” Radiation Research 199, no. 1 (2023): 1–16.

[134] W. F. Blakely, M. Port, and M. Abend, “Early-Response Multiple-Parameter Biodosimetry and Dosimetry: Risk Predictions,” Journal of Radiological Protection 41, no. 4 (2021), https://doi.org/10.1088/1361-6498/ac15df.

[135] I. Shuryak, E. Royba, M. Repin, et al., “A Machine Learning Method for Improving the Accuracy of Radiation Biodosimetry by Combining Data From the Dicentric Chromosomes and Micronucleus Assays,” Scientific Reports 12, no. 1 (2022): 21077.

[136] S. Jang, S. G. Shin, M. J. Lee, et al., “Feasibility Study on Automatic Interpretation of Radiation Dose Using Deep Learning Technique for Dicentric Chromosome Assay,” Radiation Research 195, no. 2 (2021): 163–172.

[137] X. Shen, T. Ma, C. Li, Z. Wen, J. Zheng, and Z. Zhou, “High-Precision Automatic Identification Method for Dicentric Chromosome Images Using Two-Stage Convolutional Neural Network,” Scientific Reports 13, no. 1 (2023): 2124.

[138] E. Gourd, “Potential New Method for Rapid Diagnosis of Radiation Sickness,” Lancet Oncology 21, no. 9 (2020): 1142.

[139] M. J. French, R. Wuerker, G. Dugan, et al., “Long-Term Immunological Consequences of Radiation Exposure in a Diverse Cohort of Rhesus Macaques,” International Journal of Radiation and Oncology in Biology and Physics 115, no. 4 (2023): 945–956.

[140] K. Nemeth, R. Bayraktar, M. Ferracin, and G. A. Calin, “Non-Coding RNAs in Disease: From Mechanisms to Therapeutics,” Nature Reviews Genetics 25, no. 3 (2024): 211–232.

[141] P. K. Nguyen, W. H. Lee, Y. F. Li, et al., “Assessment of the Radiation Effects of Cardiac CT Angiography Using Protein and Genetic Biomarkers,” JACC Cardiovascular Imaging 8, no. 8 (2015): 873–884.

[142] J. M. May, M. Bylicky, S. Chopra, C. N. Coleman, and M. J. Aryankalayil, “Long and Short Non-Coding RNA and Radiation Response: A Review,” Translational Research 233 (2021): 162–179.

[143] M. Yadav,·S. Bhayana, J. Liu, et al., “Two-miRNA–Based Finger-Stick Assay for Estimation of Absorbed Ionizing Radiation Do,” Science Translational Medicine 12, no. 552 (2020): eaaw5831.

[144] M. J. Cline, “Ribonucleic Acid Biosynthesis in Human Leukocytes: The Fate of Rapidly Labeled RNA in Normal and Abnormal Leukocytes,” Blood 28, no. 5 (1966): 650–664.

[145] C. Y. A. Chen, N. Ezzeddine, and A. B. Shyu, “Messenger RNA Half-Life Measurements in Mammalian Cells,” Methods in Enzymology 448 (2008): 335–357.

[146] S. Zocher, A. McCloskey, A. Karasinsky, et al., “Lifelong Persistence of Nuclear RNAs in the Mouse Brain,” Science 384, no. 6691 (2024): 53–59.

[147] C. Wang and H. Liu, “Factors Influencing Degradation Kinetics of mRNAs and Half-Lives of MicroRNAs, circRNAs, lncRNAs in Blood in Vitro Using Quantitative PCR,” Scientific Reports 12, no. 1 (2022): 7259.

[148] S. Crovella, A. Revelant, E. Muraro, et al., “Biological Pathways Associated With the Development of Pulmonary Toxicities in Mesothelioma Patients Treated With Radical Hemithoracic Radiation Therapy: A Preliminary Study,” Frontiers in Oncology 11 (2021): 784081.

[149] D. K. Soni, V. P. Kumar, S. Biswas, et al., “CDX-301 Prevents Radiation-Induced Dysregulation of miRNA Expression and Biogenesis,” Molecular Therapy Nucleic Acids 30 (2022): 569–584.

[150] L. Ma, Q. Gong, G. Liu, et al., “Positive Cofactor 4 as a Potential Radiation Biodosimeter for Early Assessment,” Dose Response 20, no. 1 (2022): 15593258221081317.

[151] O. Calvo and J. L. Manley, “The Transcriptional Coactivator PC4/Sub1 Has Multiple Functions in RNA Polymerase II Transcription,” Embo Journal 24, no. 5 (2005): 1009–1020.

[152] S. Paul and S. A. Amundson, “Development of Gene Expression Signatures for Practical Radiation Biodosimetry,” International Journal of Radiation and Oncology in Biology and Physics 71, no. 4 (2008): 1236–1244.

[153] S. A. Amundson, R. A. Lee, C. A. Koch-Paiz, et al., “Differential Responses of Stress Genes to Low Dose-Rate Gamma Irradiation,” Molecular Cancer Research : MCR 1, no. 6 (2003): 445–452.

[154] S. A. Ghandhi, L. Smilenov, I. Shuryak, M. Pujol-Canadell, and S. A. Amundson, “Discordant Gene Responses to Radiation in Humans and Mice and the Role of Hematopoietically Humanized Mice in the Search for Radiation Biomarkers,” Scientific Reports 9, no. 1 (2019): 19434.

[155] J. G. Park, S. Paul, N. Briones, et al., “Developing Human Radiation Biodosimetry Models: Testing Cross-Species Conversion Approaches Using an Ex Vivo Model System,” Radiation Research 187, no. 6 (2017): 708–721.

[156] J. D. Tucker, M. C. Joiner, R. A. Thomas, et al., “Accurate Gene Expression-Based Biodosimetry Using a Minimal Set of Human Gene Transcripts,” International Journal of Radiation Oncology, Biology, Physics 88, no. 4 (2014): 933–939.

[157] L. H. Cai, X. Y. Chen, W. Qian, et al., “DDB2 and MDM2 Genes Are Promising Markers for Radiation Diagnosis and Estimation of Radiation Dose Independent of Trauma and Burns,” Functional & Integrative Genomics 23, no. 4 (2023): 294.

[158] L. Ma, Z. Hu, Y. Chen, Z. Cheng, and C. Shi, “Characterization of Two Stable Biodosimeters for Absorbed Ionizing Radiation Dose Estimation in Multiple Combined Injury Models,” Radiation Research 204 (2025): 27–45.

[159] M. Correia de Sousa, M. Gjorgjieva, D. Dolicka, C. Sobolewski, and M. Foti, “Deciphering miRNAs' Action Through miRNA Editing,” International Journal of Molecular Sciences 20, no. 24 (2019): 6249.

[160] L. Statello, C. J. Guo, L. L. Chen, and M. Huarte, “Gene Regulation by Long Non-Coding RNAs and Its Biological Functions,” Nature Reviews Molecular Cell Biology 22, no. 2 (2021): 96–118.

[161] X. D. Xiong, X. Ren, M. Y. Cai, J. W. Yang, X. Liu, and J. M. Yang, “Long Non-Coding RNAs: An Emerging Powerhouse in the Battle Between Life and Death of Tumor Cells,” Drug Resistance Updates 26 (2016): 28–42.

[162] Y. Zhang, W. Du, and B. Yang, “Long Non-Coding RNAs as New Regulators of Cardiac Electrophysiology and Arrhythmias: Molecular Mechanisms, Therapeutic Implications and Challenges,” Pharmacology & Therapeutics 203 (2019): 107389.

[163] R. Kunze, S. Fischer, H. H. Marti, and K. T. Preissner, “Brain Alarm by Self-Extracellular Nucleic Acids: From Neuroinflammation to Neurodegeneration,” Journal of Biomedical Science 30, no. 1 (2023): 64.

[164] M. J. Aryankalayil, M. A. Bylicky, S. Martello, et al., “Microarray Analysis Identifies Coding and Non-Coding RNA Markers of Liver Injury in Whole Body Irradiated Mice,” Scientific Reports 13, no. 1 (2023): 200.

[165] E. Russ, O. O. Fatanmi, S. Y. Wise, et al., “Serum microRNA Profile of Rhesus Macaques Following Ionizing Radiation Exposure and Treatment With a Medical Countermeasure, Ex-Rad,” Scientific Reports 14, no. 1 (2024): 4518.

[166] Y. Li, J. Singh, R. Varghese, et al., “Transcriptome of Rhesus Macaque (Macaca Mulatta) Exposed to Total-Body Irradiation,” Scientific Reports 11, no. 1 (2021): 6295.

[167] N. K. Jacob, J. V. Cooley, T. N. Yee, et al., “Identification of Sensitive Serum microRNA Biomarkers for Radiation Biodosimetry,” PLoS ONE 8, no. 2 (2013): e57603.

[168] N. I. Ossetrova, P. Stanton, K. Krasnopolsky, M. Ismail, A. Doreswamy, and K. P. Hieber, “Comparison of Biodosimetry Biomarkers for Radiation Dose and Injury Assessment after Mixed-Field (Neutron and Gamma) and Pure Gamma Radiation in the Mouse Total-Body Irradiation Model,” Health Physics 115, no. 6 (2018): 743–759.

[169] A. C. M. Mfossa, H. Thekkekara Puthenparampil, A. Inalegwu, et al., “Exposure to Ionizing Radiation Triggers Prolonged Changes in Circular RNA Abundance in the Embryonic Mouse Brain and Primary Neurons,” Cells 8, no. 8 (2019): 778.

[170] B. Chen, M. P. Dragomir, C. Yang, Q. Li, D. Horst, and G. A. Calin, “Targeting Non-Coding RNAs to Overcome Cancer Therapy Resistance,” Signal Transduction and Targeted Therapy 7, no. 1 (2022): 121.

[171] X. L. Tian, T. T. Zhang, T. J. Cai, M. Tian, and Q. J. Liu, “Screening Radiation-Differentially Expressed Circular RNAs and Establishing Dose Classification Models in the Human Lymphoblastoid Cell Line AHH-1,” International Journal of Radiation Biology 100, no. 4 (2024): 550–564.

[172] H. Chen, X. Zhao, W. Yang, et al., “RNA N6-Methyladenosine Modification-Based Biomarkers for Absorbed Ionizing Radiation Dose Estimation,” Nature Communications 14, no. 1 (2023): 6912.

[173] M. J. Aryankalayil, S. Martello, M. A. Bylicky, et al., “Analysis of lncRNA-miRNA-mRNA Expression Pattern in Heart Tissue After Total Body Radiation in a Mouse Model,” Journal of Translational Medicine 19, no. 1 (2021): 336.

[174] M. Chiba, H. Uehara, I. Niiyama, H. Kuwata, and S. Monzen, “Changes in miRNA Expressions in the Injured Small Intestine of Mice Following High‑Dose Radiation Exposure,” Molecular Medicine Reports 21, no. 6 (2020): 2452–2458.

[175] S. H. Jeon, E. K. Chie, Y. J. Kim, et al., “Targeted Next-Generation DNA Sequencing Identifies Notch Signaling Pathway Mutation as a Predictor of Radiation Response,” International Journal of Radiation Biology 95, no. 12 (2019): 1640–1647.

[176] S. Li, X. Lu, J. B. Feng, et al., “Developing Gender-Specific Gene Expression Biodosimetry Using a Panel of Radiation-Responsive Genes for Determining Radiation Dose in Human Peripheral Blood,” Radiation Research 192, no. 4 (2019): 399–409.

[177] M. Bugden, S. Billing, K. C. Mak, F. Norton, D. Klokov, and Y. Wang, “Ionizing Radiation Affects miRNA Composition in Both Young and Old Mice,” International Journal of Radiation Biology 95, no. 10 (2019): 1404–1413.

[178] A. J. Garcia-Sanchez, E. A. Garcia Angosto, P. A. Moreno Riquelme, A. Serna Berna, and D. Ramos-Amores, “Ionizing Radiation Measurement Solution in a Hospital Environment,” Sensors (Basel) 18, no. 2 (2018): 510.

[179] S. A. Ghandhi, I. Shuryak, B. Ponnaiya, et al., “Cross-Platform Validation of a Mouse Blood Gene Signature for Quantitative Reconstruction of Radiation Dose,” Scientific Reports 12, no. 1 (2022): 14124.

[180] H. L. Kaatsch, M. Majewski, G. Schrock, et al., “CT Irradiation-Induced Changes of Gene Expression Within Peripheral Blood Cells,” Health Physics 119, no. 1 (2020): 44–51.

[181] C. G. Broustas, Y. Xu, A. D. Harken, M. Chowdhury, G. Garty, and S. A. Amundson, “Impact of Neutron Exposure on Global Gene Expression in a Human Peripheral Blood Model,” Radiation Research 187, no. 4 (2017): 433–440.

[182] S. Paul, N. J. Kleiman, and S. A. Amundson, “Transcriptomic Responses in Mouse Blood During the First Week After in Vivo Gamma Irradiation,” Scientific Reports 9, no. 1 (2019): 18364.

[183] S. K. Meadows, H. K. Dressman, G. G. Muramoto, et al., “Gene Expression Signatures of Radiation Response Are Specific, Durable and Accurate in Mice and Humans,” PLoS ONE 3, no. 4 (2008): e1912.

[184] K. Szołtysek, P. Janus, G. Zając, et al., “RRAD, IL4I1, CDKN1A, and SERPINE1 Genes Are Potentially Co-Regulated by NF-κB and P53 Transcription Factors in Cells Exposed to High Doses of Ionizing Radiation,” BMC Genomics 19, no. 1 (2018): 813.

[185] M. R. Hoffmeyer, K. Gillis, J. G. Park, V. Murugan, and J. LaBaer, “Making the Case for Absorbed Radiation Response Biodosimetry—Utility of a High-Throughput Biodosimetry System,” Radiation Research 196, no. 5 (2021): 535–546.

[186] S. S. Acharya, W. Fendler, J. Watson, et al., “Serum MicroRNAs Are Early Indicators of Survival After Radiation-Induced Hematopoietic Injury,” Science Translational Medicine 7, no. 287 (2015): 287ra69.

[187] C. H. Du, Y. D. Wu, K. Yang, et al., “Apoptosis-Resistant Megakaryocytes Produce Large and Hyperreactive Platelets in Response to Radiation Injury,” Military Medical Research 10, no. 1 (2023): 66.

[188] M. Port, F. Hérodin, M. Valente, et al., “Gene Expression Signature for Early Prediction of Late Occurring Pancytopenia in Irradiated Baboons,” Annal of Hematology 96, no. 5 (2017): 859–870.

[189] O. Howe, L. White, D. Cullen, et al., “A 4-Gene Signature of CDKN1, FDXR, SESN1 and PCNA Radiation Biomarkers for Prediction of Patient Radiosensitivity,” International Journal of Molecular Sciences 22, no. 19 (2021): 10607.

[190] S. Schüle, P. Ostheim, M. Port, and M. Abend, “Identifying Radiation Responsive Exon-Regions of Genes Often Used for Biodosimetry and Acute Radiation Syndrome Prediction,” Scientific Reports 12, no. 1 (2022): 9545.

[191] S. A. Amundson, K. T. Do, and A. J. Fornace, “Induction of Stress Genes by Low Doses of Gamma Rays,” Radiation Research 152, no. 3 (1999): 225–231.

[192] J. Lacombe, C. Sima, S. A. Amundson, and F. Zenhausern, “Candidate Gene Biodosimetry Markers of Exposure to External Ionizing Radiation in Human Blood: A Systematic Review,” PLoS ONE 13, no. 6 (2018): e0198851.

[193] S. A. Amundson, K. T. Do, S. Shahab, et al., “Identification of Potential mRNA Biomarkers in Peripheral Blood Lymphocytes for Human Exposure to Ionizing Radiation,” Rare 154, no. 3 (2000): 342–346.

[194] A. Tahamtan, M. Teymoori-Rad, B. Nakstad, and V. Salimi, “Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment,” Frontiers in Immunology 9 (2018): 1377.

[195] Y. Zhang, J. Liu, L. Zhou, et al., “Exosomal Small RNA Sequencing Uncovers Dose-Specific MiRNA Markers for Ionizing Radiation Exposure,” Dose-Response 18, no. 2 (2020): 1559325820926735.

[196] B. Tsogbadrakh, J. A. Jung, M. Lee, J. A. Lee, and J. H. Seo, “Identifying Serum miRNA Biomarkers for Radiation Exposure in Hematopoietic Humanized NSG-SGM3 Mice,” Biochemical and Biophysical Research Communications 599 (2022): 51–56.

[197] S. Martello, M. A. Bylicky, U. Shankavaram, et al., “Comparative Analysis of miRNA Expression After Whole-Body Irradiation Across Three Strains of Mice,” Radiation Research 200, no. 3 (2023): 266–280.

[198] M. Port, F. Herodin, M. Valente, et al., “MicroRNA Expression for Early Prediction of Late Occurring Hematologic Acute Radiation Syndrome in Baboons,” PLoS ONE 11, no. 11 (2016): e0165307.

[199] N. Menon, C. J. Rogers, A. I. Lukaszewicz, et al., “Detection of Acute Radiation Sickness: A Feasibility Study in Non-Human Primates Circulating miRNAs for Triage in Radiological Events,” PLoS ONE 11, no. 12 (2016): e0167333.

[200] J. Peterson, C. D. McTiernan, C. Thome, et al., “Identification of Radiation-Induced miRNA Biomarkers Using the CGL1 Cell Model System,” Bioengineering 9, no. 5 (2022): 214.

[201] S. Chopra, U. Shankavaram, M. Bylicky, et al., “Profiling mRNA, miRNA and lncRNA Expression Changes in Endothelial Cells in Response to Increasing Doses of Ionizing Radiation,” Scientific Reports 12, no. 1 (2022): 19941.

[202] E. L. Pannkuk, E. C. Laiakis, G. Garty, et al., “Biofluid Metabolomics and Lipidomics of Mice Exposed to External Very High-Dose Rate Radiation,” Metabolites 12, no. 6 (2022): 520.

[203] L. Sun, Y. Inaba, N. Kanzaki, M. Bekal, K. Chida, and T. Moritake, “Identification of Potential Biomarkers of Radiation Exposure in Blood Cells by Capillary Electrophoresis Time-of-Flight Mass Spectrometry,” International Journal of Molecular Sciences 21, no. 3 (2020): 812.

[204] C. M. Kang, J. Seong Hyeon, S. Ra Kim, et al., “Application of NMR Spectroscopy in the Assessment of Radiation Dose in Human Primary Cells,” Chemistry and Biodiversity 12, no. 11 (2015): 1696–1705.

[205] D. D. Marshall and R. Powers, “Beyond the Paradigm: Combining Mass Spectrometry and Nuclear Magnetic Resonance for Metabolomics,” Progress in Nuclear Magnetic Resonance Spectroscopy 100 (2017): 1–16.

[206] M. P. M. Letertre, P. Giraudeau, and P. de Tullio, “Nuclear Magnetic Resonance Spectroscopy in Clinical Metabolomics and Personalized Medicine: Current Challenges and Perspectives,” Frontiers in Molecular Biosciences 8 (2021): 698337.

[207] A. H. Emwas, R. Roy, R. T. McKay, et al., “NMR Spectroscopy for Metabolomics Research,” Metabolites 9, no. 7 (2019): 123.

[208] K. Maan, R. Baghel, S. Dhariwal, A. Sharma, R. Bakhshi, and P. Rana, “Metabolomics and Transcriptomics Based Multi-Omics Integration Reveals Radiation-Induced Altered Pathway Networking and Underlying Mechanism,” npj Systems Biology and Applications 9, no. 1 (2023): 42.

[209] A. Becciolini, S. Porciani, A. Lanini, A. Benucci, A. Castagnoli, and A. Pupi, “Serum Amylase and Tissue Polypeptide Antigen as Biochemical Indicators of Salivary Gland Injury During Iodine-131 Therapy,” European Journal of Nuclear Medicine 21, no. 10 (1994): 1121–1125.

[210] P. Milne, C. Wilhelm-Benartzi, M. R. Grunwald, et al., “Serum Flt3 Ligand Is a Biomarker of Progenitor Cell Mass and Prognosis in Acute Myeloid Leukemia,” Blood Advances 3, no. 20 (2019): 3052–3061.

[211] P. Kumar, P. Wang, G. Tudor, et al., “Evaluation of Plasma Biomarker Utility for the Gastrointestinal Acute Radiation Syndrome in Non-Human Primates After Partial Body Irradiation With Minimal Bone Marrow Sparing Through Correlation With Tissue and Histological Analyses,” Health Physics 119, no. 5 (2020): 594–603.

[212] H. Zhao, C. Xi, M. Tian, et al., “Identification of Potential Radiation Responsive Metabolic Biomarkers in Plasma of Rats Exposed to Different Doses of Cobalt-60 Gamma Rays,” Dose Response 18, no. 4 (2020): 1559325820979570.

[213] M. Salah, S. Osuga, M. Nakahana, et al., “Elucidation of Gastrointestinal Dysfunction in Response to Irradiation Using Metabolomics,” Biochemistry and Biophysics Reports 23 (2020): 100789.

[214] S. Xu, H. Wang, L. Yan, and X. Han, “Isoegomaketone Improves Radiotherapy Efficacy and Intestinal Injury by Regulating Apoptosis, Autophagy and PI3K/AKT/mTOR Signaling in a Colon Cancer Model,” Oncology Reports 53, no. 4 (2025): 51.

[215] Q. Mao, W. Zhang, Y. Zhang, B. Lin, Q. Cao, and M. Xu, “P036 Microbiota Metabolite Butyrate Attenuates Intestinal Inflammation Through Autophagy Activation,” Journal of Crohn's and Colitis 18, no. S_1 (2024): i294–i295.

[216] F. Zhang, T. Liu, H. C. Huang, et al., “Activation of Pyroptosis and Ferroptosis Is Involved in Radiation-Induced Intestinal Injury in Mice,” Biochemical and Biophysical Research Communications 631 (2022): 102–109.

[217] X. Zhou, H. Wang, D. Li, N. Song, F. Yang, and W. Xu, “MST1/2 Inhibitor XMU-MP-1 Alleviates the Injury Induced by Ionizing Radiation in Haematopoietic and Intestinal System,” Journal of Cellular and Molecular Medicine 26, no. 5 (2022): 1621–1628.

[218] S. Kong, Y. H. Zhang, and W. Zhang, “Regulation of Intestinal Epithelial Cells Properties and Functions by Amino Acids,” BioMed Research International 2018 (2018): 2819154.

[219] C. Ji, M. Wu, J. Zou, et al., “Protection of γ-Amino Butyric Acid on Radiation Induced Intestinal Injury in Mice,” Molecular Nutrition & Food Research 67, no. 10 (2023): e2200522.

[220] M. Aryankalayil, M. A. Bylicky, S. Chopra, et al., “Biomarkers for Biodosimetry and Their Role in Predicting Radiation Injury,” Cytogenetic and Genome Research 163, no. 3 (2023): 103–109.

[221] M. M. Satyamitra, D. R. Cassatt, B. A. Hollingsworth, et al., “Metabolomics in Radiation Biodosimetry: Current Approaches and Advances,” Metabolites 10, no. 8 (2020): 328.

[222] E. C. Laiakis, S. J. Strawn, D. J. Brenner, and A. J. Fornace, “Assessment of Saliva as a Potential Biofluid for Biodosimetry: A Pilot Metabolomics Study in Mice,” Radiation Research 186, no. 1 (2016): 92–97.

[223] J. B. Tyburski, A. D. Patterson, K. W. Krausz, et al., “Radiation Metabolomics. 1. Identification of Minimally Invasive Urine Biomarkers for Gamma-Radiation Exposure in Mice,” Radiation Research 170, no. 1 (2008): 1–14.

[224] E. L. Pannkuk, E. C. Laiakis, G. Garty, et al., “Impact of Partial Body Shielding From Very High Dose Rates on Untargeted Metabolomics in Biodosimetry,” ACS Omega 9, no. 32 (2024): 35182–35196.

[225] E. L. Pannkuk, E. C. Laiakis, M. Garcia, A. J. Fornace, and V. K. Singh, “Nonhuman Primates With Acute Radiation Syndrome: Results From a Global Serum Metabolomics Study After 7.2 Gy Total-Body Irradiation,” Rare 190, no. 6 (2018): 576–583.

[226] U. S. Kumta and A. L. Tappel, “Radiation Damage to Proteins,” Nature 191 (1961): 1304–1305.

[227] M. Mehta, R. Raguraman, R. Ramesh, and A. Munshi, “RNA Binding Proteins (RBPs) and Their Role in DNA Damage and Radiation Response in Cancer,” Advanced Drug Delivery Reviews 191 (2022): 114569.

[228] S. Dobersch, K. Rubio, I. Singh, et al., “Positioning of Nucleosomes Containing γ-H2AX Precedes Active DNA Demethylation and Transcription Initiation,” Nature Communications 12, no. 1 (2021): 1072.

[229] J. Atkinson, E. Bezak, H. Le, and I. Kempson, “DNA Double Strand Break and Response Fluorescent Assays: Choices and Interpretation,” International Journal of Molecular Sciences 25, no. 4 (2024): 2227.

[230] M. Moroni, D. Maeda, M. H. Whitnall, W. M. Bonner, and C. E. Redon, “Evaluation of the Gamma-H2AX Assay for Radiation Biodosimetry in a Swine Model,” International Journal of Molecular Sciences 14, no. 7 (2013): 14119–14135.

[231] D. Ramadhani, D. Tetriana, S. Purnami, et al., “γ-H2AX and Phospho-ATM Enzyme-Linked Immunosorbent Assays as Biodosimetry Methods for Radiation Exposure Assessment: A Pilot Study,” Radiation Protection Dosimetry 199, no. 19 (2023): 2383–2390.

[232] M. Flegal, M. S. Blimkie, H. Wyatt, M. Bugden, J. Surette, and D. Klokov, “Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic in Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation,” Journal of Visualized Experiments: JoVE, no. 101 (2015): e52912.

[233] L. Paris, E. Cordelli, P. Eleuteri, et al., “Kinetics of Gamma-H2AX Induction and Removal in Bone Marrow and Testicular Cells of Mice After X-Ray Irradiation,” Mutagenesis 26, no. 4 (2011): 563–572.

[234] J. E. González, S. H. Roch-Lefèvre, T. Mandina, O. García, and L. Roy, “Induction of Gamma-H2AX Foci in Human Exfoliated Buccal Cells After in Vitro Exposure to Ionising Radiation,” International Journal of Radiation Biology 86, no. 9 (2010): 752–759.

[235] J. Bensimon Etzol, S. Bouvet, C. Bettencourt, et al., “DosiKit, a New Immunoassay for Fast Radiation Biodosimetry of Hair and Blood Samples,” Radiation Research 190, no. 5 (2018): 473–482.

[236] C. E. Redon, A. J. Nakamura, O. Sordet, et al., “γ-H2AX Detection in Peripheral Blood Lymphocytes, Splenocytes, Bone Marrow, Xenografts, and Skin,” Methods in Molecular Biology 682 (2011): 249–270.

[237] R. Wanotayan, K. Chousangsuntorn, P. Petisiwaveth, et al., “A Deep Learning Model (FociRad) for Automated Detection of γ-H2AX Foci and Radiation Dose Estimation,” Scientific Reports 12, no. 1 (2022): 5527.

[238] R. Wanotayan, S. Wongsanit, K. Boonsirichai, et al., “Quantification of Histone H2AX Phosphorylation in White Blood Cells Induced by Ex Vivo Gamma Irradiation of Whole Blood by Both Flow Cytometry and Foci Counting as a Dose Estimation in Rapid Triage,” PLoS ONE 17, no. 3 (2022): e0265643.

[239] D. Heylmann and B. Kaina, “The γH2AX DNA Damage Assay From a Drop of Blood,” Scientific Reports 6 (2016): 22682.

[240] Y. Han, Y. Gu, A. C. Zhang, and Y. H. Lo, “Review: Imaging Technologies for Flow Cytometry,” Lab on A Chip 16, no. 24 (2016): 4639–4647.

[241] Y. Lee, Q. Wang, I. Shuryak, D. J. Brenner, and H. C. Turner, “Development of a High-Throughput γ-H2AX Assay Based on Imaging Flow Cytometry,” Radiation Oncology 14, no. 1 (2019): 150.

[242] J. L. Sun, S. Li, X. Lu, et al., “Identification of the Differentially Expressed Protein Biomarkers in Rat Blood Plasma in Response to Gamma Irradiation,” International Journal of Radiation Biology 96, no. 6 (2020): 748–758.

[243] S. A. Ghandhi, S. R. Morton, I. Shuryak, et al., “Longitudinal Multi-Omic Changes in the Transcriptome and Proteome of Peripheral Blood Cells After a 4 Gy Total Body Radiation Dose to Rhesus Macaques,” BMC Genomics 24, no. 1 (2023): 139.

[244] S. D. Byrum, M. S. Burdine, L. Orr, et al., “Time- and Radiation-Dose Dependent Changes in the Plasma Proteome After Total Body Irradiation of Non-Human Primates: Implications for Biomarker Selection,” PLoS ONE 12, no. 3 (2017): e0174771.

[245] M. Sproull, D. Nishita, P. Chang, et al., “Comparison of Proteomic Expression Profiles After Radiation Exposure Across Four Different Species,” Radiation Research 197, no. 4 (2022): 315–323.

[246] N. Dainiak and B. J. Tan, “Utility of Biological Membranes as Indicators for Radiation Exposure: Alterations in Membrane Structure and Function Over Time,” Stem Cells 13, no. S1 (1995): 142–152.

[247] O. I. Shadyro, I. L. Yurkova, and M. A. Kisel, “Radiation-Induced Peroxidation and Fragmentation of Lipids in a Model Membrane,” International Journal of Radiation Biology 78, no. 3 (2002): 211–217.

[248] A. D. Carpenter, Y. Li, O. O. Fatanmi, et al., “Metabolomic Profiles in Tissues of Nonhuman Primates Exposed to Either Total- or Partial-Body Radiation,” Radiation Research 201, no. 5 (2024): 371–383.

[249] E. C. Laiakis, K. Strassburg, R. Bogumil, et al., “Metabolic Phenotyping Reveals a Lipid Mediator Response to Ionizing Radiation,” Journal of Proteome Research 13, no. 9 (2014): 4143–4154.

[250] E. L. Pannkuk, E. C. Laiakis, T. D. Mak, et al., “A Lipidomic and Metabolomic Serum Signature From Nonhuman Primates Exposed to Ionizing Radiation,” Metabolomics 12, no. 5 (2016): 80.

[251] Y. Tian, Z. Xia, M. Li, et al., “The Relationship Between Microwave Radiation Injury and Abnormal Lipid Metabolism,” Chemistry and Physics of Lipids 225 (2019): 104802.

[252] T. Wang, X. Fu, Q. Chen, et al., “Arachidonic Acid Metabolism and Kidney Inflammation,” International Journal of Molecular Sciences 20, no. 15 (2019): 3683.

[253] P. Bahrami, K. A. Aromolaran, and A. S. Aromolaran, “Proarrhythmic Lipid Inflammatory Mediators: Mechanisms in Obesity Arrhythmias,” Journal of Cellular Physiology 240, no. 2 (2025): e70012.

[254] A. K. Cheema, K. Y. Mehta, O. O. Fatanmi, et al., “A Metabolomic and Lipidomic Serum Signature From Nonhuman Primates Administered With a Promising Radiation Countermeasure, Gamma-Tocotrienol,” International Journal of Molecular Sciences 19, no. 1 (2017): 79.

[255] C. Morin, A. M. Cantin, F. A. Vézina, and S. Fortin, “The Efficacy of MAG-DHA for Correcting AA/DHA Imbalance of Cystic Fibrosis Patients,” Marine Drugs 16, no. 6 (2018): 184.

[256] Y. Tatara and S. Monzen, “Proteomics and Secreted Lipidomics of Mouse-Derived Bone Marrow Cells Exposed to a Lethal Level of Ionizing Radiation,” Scientific Reports 13, no. 1 (2023): 8802.

[257] Q. Chen, H. Zhao, C. Xi, et al., “Targeted Lipidomics-Based Study of Radiation-Induced Metabolite Profiles Changes in Plasma of Total Body Irradiation Cases,” International Journal of Radiation Biology 100, no. 10 (2024): 1481–1492.

[258] M. Goudarzi, T. D. Mak, J. P. Jacobs, et al., “An Integrated Multi-Omic Approach to Assess Radiation Injury on the Host-Microbiome Axis,” Radiation Research 186, no. 3 (2016): 219–234.

[259] C. Chen, D. J. Brenner, and T. R. Brown, “Identification of Urinary Biomarkers From X-Irradiated Mice Using NMR Spectroscopy,” Rare 175, no. 5 (2011): 622–630.

[260] E. C. Laiakis, D. R. Hyduke, and A. J. Fornace, “Comparison of Mouse Urinary Metabolic Profiles After Exposure to the Inflammatory Stressors γ Radiation and Lipopolysaccharide,” Rare 177, no. 2 (2012): 187–199.

[261] C. H. Johnson, A. D. Patterson, K. W. Krausz, et al., “Radiation Metabolomics. 4. UPLC-ESI-QTOFMS-Based Metabolomics for Urinary Biomarker Discovery in Gamma-Irradiated Rats,” Rare 175, no. 4 (2011): 473–484.

[262] J. W. Jones, J. Alloush, R. Sellamuthu, et al., “Effect of Sex on Biomarker Response in a Mouse Model of the Hematopoietic Acute Radiation Syndrome,” Health Physics 116, no. 4 (2019): 484–502.

[263] J. W. Jones, Z. Clifford, F. Li, et al., “Targeted Metabolomics Reveals Metabolomic Signatures Correlating Gastrointestinal Tissue to Plasma in a Mouse Total-Body Irradiation Model,” Health Physics 116, no. 4 (2019): 473.

[264] Z. Chen, S. L. Coy, E. L. Pannkuk, E. C. Laiakis, A. J. Fornace, and P. Vouros, “Differential Mobility Spectrometry-Mass Spectrometry (DMS-MS) in Radiation Biodosimetry: Rapid and High-Throughput Quantitation of Multiple Radiation Biomarkers in Nonhuman Primate Urine,” Journal of the American Society for Mass Spectrometry 29, no. 8 (2018): 1650–1664.

[265] C. H. Johnson, A. D. Patterson, K. W. Krausz, et al., “Radiation Metabolomics. 5. Identification of Urinary Biomarkers of Ionizing Radiation Exposure in Nonhuman Primates by Mass Spectrometry-Based Metabolomics,” Rare 178, no. 4 (2012): 328–340.

[266] E. L. Pannkuk, E. C. Laiakis, S. Authier, K. Wong, and A. J. Fornace, “Gas Chromatography/Mass Spectrometry Metabolomics of Urine and Serum From Nonhuman Primates Exposed to Ionizing Radiation: Impacts on the Tricarboxylic Acid Cycle and Protein Metabolism,” Journal of Proteome Research 16, no. 5 (2017): 2091–2100.

[267] E. C. Laiakis, T. D. Mak, S. Anizan, et al., “Development of a Metabolomic Radiation Signature in Urine From Patients Undergoing Total Body Irradiation,” Radiation Research 181, no. 4 (2014): 350–361.

[268] C. P. Hinzman, M. Jayatilake, S. Bansal, et al., “An Optimized Method for the Isolation of Urinary Extracellular Vesicles for Molecular Phenotyping: Detection of Biomarkers for Radiation Exposure,” Journal of Translational Medicine 20, no. 1 (2022): 199.

[269] T. Vicar, J. Gumulec, R. Kolar, et al., “DeepFoci: Deep Learning-Based Algorithm for Fast Automatic Analysis of DNA Double-Strand Break Ionizing Radiation-Induced Foci,” Computational and Structural Biotechnology Journal 19 (2021): 6465–6480.

[270] Z. Jin, Z. Dong, X. Zhao, et al., “Sensitive, Rapid Detection of NCOA4-m6A Towards Precisely Quantifying Radiation Dosage on a Cas13a-Microdroplet Platform,” Biosensors & Bioelectronics 242 (2023): 115753.

[271] J. C. Larsen and G. L. Disbrow, “Project BioShield and the Biomedical Advanced Research Development Authority: A Ten Year Progress Report on Meeting U.S. Preparedness Objectives for Threat Agents,” Clinical Infectious Diseases 64, no. 10 (2017): 1430–1434.

[272] R. P. Balog, P. Chang, H. S. Javitz, et al., “Development of a Point-of-Care Radiation Biodosimeter: Studies Using Novel Protein Biomarker Panels in Non-Human Primates,” International Journal of Radiation Biology 96, no. 1 (2020): 35–46.

[273] A. R. Jacobs, T. Guyon, V. Headley, et al., “Role of a High Throughput Biodosimetry Test in Treatment Prioritization After a Nuclear Incident,” International Journal of Radiation Biology 96, no. 1 (2020): 57–66.

[274] A. Bertucci, L. B. Smilenov, H. C. Turner, S. A. Amundson, and D. J. Brenner, “In Vitro RABiT Measurement of Dose Rate Effects on Radiation Induction of Micronuclei in Human Peripheral Blood Lymphocytes,” Radiation and Environmental Biophysics 55, no. 1 (2016): 53–59.

[275] A. Vral, M. Fenech, and H. Thierens, “The Micronucleus Assay as a Biological Dosimeter of in Vivo Ionising Radiation Exposure,” Mutagenesis 26, no. 1 (2011): 11–17.

[276] C. Capaccio, J. R. Perrier, L. Cunha, et al., “CytoRADx: A High-Throughput, Standardized Biodosimetry Diagnostic System Based on the Cytokinesis-Block Micronucleus Assay,” Radiation Research 196, no. 5 (2021): 523–534.

[277] C. Schunck, T. Lörch, R. Kowalski, et al., “A Standardized and Automated CBMN Assay for Biological Dosimetry: The CytoRADxTM System,” Radiation Protection Dosimetry 199, no. 14 (2023): 1516–1519.

[278] M. S. Chesnokov, A. R. Mamedova, B. Zhivotovsky, and G. S. Kopeina, “A Matter of New Life and Cell Death: Programmed Cell Death in the Mammalian Ovary,” Journal of Biomedical Science 31, no. 1 (2024): 31.

[279] L. Barazzuol, S. R. Hopkins, L. Ju, and P. A. Jeggo, “Distinct Response of Adult Neural Stem Cells to Low Versus High Dose Ionising Radiation,” DNA Repair 76 (2019): 70–75.

[280] N. Popgeorgiev, J. D. Sa, L. Jabbour, et al., “Ancient and Conserved Functional Interplay Between Bcl-2 Family Proteins in the Mitochondrial Pathway of Apoptosis,” Science Advances 6, no. 40 (2020): eabc4149.

[281] Y. Jo, G. Oh, Y. Gi, et al., “Tumor Treating Fields (TTF) Treatment Enhances Radiation-Induced Apoptosis in Pancreatic Cancer Cells,” International Journal of Radiation Biology 96, no. 12 (2020): 1528–1533.

[282] W. Zhao, Z. Chen, W. Fu, et al., “Induction of Apoptosis and Hypoxic Stress in Malignant Melanoma Cells via Graphene-Mediated Far-Infrared Radiation,” BMC Cancer 25, no. 1 (2025): 620.

[283] C. Zhao, S. Qiu, J. He, et al., “Prodigiosin Impairs Autophagosome-Lysosome Fusion That Sensitizes Colorectal Cancer Cells to 5-Fluorouracil-Induced Cell Death,” Cancer Letters 481 (2020): 15–23.

[284] Y. Wei, G. Xiao, H. Xu, et al., “Radiation Resistance of Cancer Cells Caused by Mitochondrial Dysfunction Depends on <Scp>SIRT3</Scp>-Mediated Mitophagy,” FEBS Journal 290, no. 14 (2023): 3629–3645.

[285] L. Seifert and G. Miller, “Molecular Pathways: The Necrosome—A Target for Cancer Therapy,” Clinical Cancer Research 23, no. 5 (2017): 1132–1136.

[286] L. Nicolè, T. Sanavia, R. Cappellesso, et al., “Necroptosis-Driving Genes RIPK1, RIPK3 and MLKL-pAre Associated With Intratumoral CD3+and CD8+T Cell Density and Predict Prognosis in Hepatocellular Carcinoma,” Journal for ImmunoTherapy of Cancer 10, no. 3 (2022): e004031.

[287] Y. Wang, M. Zhao, S. He, et al., “Necroptosis Regulates Tumor Repopulation After Radiotherapy via RIP1/RIP3/MLKL/JNK/IL8 Pathway,” Journal of Experimental & Clinical Cancer Research 38, no. 1 (2019): 461.

[288] M. Jiang, P. Chen, L. Wang, et al., “cGAS-STING, an Important Pathway in Cancer Immunotherapy,” Journal of Hematology & Oncology 13, no. 1 (2020): 81.

[289] G. Brumatti, C. Ma, N. Lalaoui, et al., “The Caspase-8 Inhibitor Emricasan Combines With the SMAC Mimetic Birinapant to Induce Necroptosis and Treat Acute Myeloid Leukemia,” Science Translational Medicine 8, no. 339 (2016): 339ra69.

[290] A. Janthong, K. Utama, N. Khamto, et al., “Semi-Synthetic Flavonoid Derivatives From Boesenbergia Rotunda Induce Extrinsic Apoptosis Pathway via Caspase-3 and Caspase-8 in HCT116 Colon Cancer Cell Lines,” Bioorganic Chemistry 159 (2025): 108343.

[291] B. Uzunparmak, M. Gao, A. Lindemann, et al., “Caspase-8 Loss Radiosensitizes Head and Neck Squamous Cell Carcinoma to SMAC Mimetic–Induced Necroptosis,” JCI Insight 5, no. 23 (2020): e139837.

[292] A. Dahiya, S. Sharma, P. K. Agrawala, and A. Dutta, “Histone Deacetylase Inhibitor, Trichostatin A Mitigates Ionizing Radiation Induced Redox Imbalance by Regulating NRF2/GPX4/PINK1/PARKIN Signaling in Mice Intestine,” Molecular Biology Reports 51, no. 1 (2024): 943.

[293] S. E. Jung, J. S. Ahn, Y. H. Kim, H. J. Oh, B. J. Kim, and B. Y. Ryu, “Necrostatin-1 Improves the Cryopreservation Efficiency of Murine Spermatogonial Stem Cells via Suppression of Necroptosis and Apoptosis,” Theriogenology 158 (2020): 445–453.

[294] J. Strandberg, A. Louie, S. Lee, et al., “TRAIL Agonists Rescue Mice From Radiation-Induced Lung, Skin, or Esophageal Injury,” Journal of Clinical Investigation 135, no. 5 (2025): e173649.

[295] A. Zahid, H. Ismail, and T. Jin, “Molecular and Structural Aspects of Gasdermin Family Pores and Insights Into Gasdermin-Elicited Programmed Cell Death,” Biochemical Society Transactions 49, no. 6 (2021): 2697–2710.

[296] X. Tong, R. Tang, M. Xiao, et al., “Targeting Cell Death Pathways for Cancer Therapy: Recent Developments in Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis Research,” Journal of Hematology & Oncology 15, no. 1 (2022): 174.

[297] W. Cao, G. Chen, L. Wu, et al., “Ionizing Radiation Triggers the Antitumor Immunity by Inducing Gasdermin E-Mediated Pyroptosis in Tumor Cells,” International Journal of Radiation Oncology*Biology*Physics 115, no. 2 (2023): 440–452.

[298] N. Rahmanian, S. J. Hosseinimehr, and A. Khalaj, “The Paradox Role of Caspase Cascade in Ionizing Radiation Therapy,” Journal of Biomedical Science 23, no. 1 (2016): 88.

[299] J. Lin, S. Sun, K. Zhao, et al., “Oncolytic Parapoxvirus Induces Gasdermin E-Mediated Pyroptosis and Activates Antitumor Immunity,” Nature Communications 14, no. 1 (2023): 224.

[300] S. Deng, Y. Yang, S. He, et al., “FlaA N/C Attenuates Radiation-Induced Lung Injury by Promoting NAIP/NLRC4/ASC Inflammasome Autophagy and Inhibiting Pyroptosis,” Journal of Translational Medicine 23, no. 1 (2025): 237.

[301] Y. Zhang, Z. Li, W. Hong, et al., “STING-Dependent Sensing of Self-DNA Driving Pyroptosis Contributes to Radiation-Induced Lung Injury,” International Journal of Radiation Oncology*Biology*Physics 117, no. 4 (2023): 928–941.

[302] L. K. Tan, J. Liu, C. Z. Ma, et al., “Iron-Dependent Cell Death: Exploring Ferroptosis as a Unique Target in Triple-Negative Breast Cancer Management,” CMAR 17 (2025): 625–637.

[303] G. Lei, Y. Zhang, P. Koppula, et al., “The Role of Ferroptosis in Ionizing Radiation-Induced Cell Death and Tumor Suppression,” Cell Research 30, no. 2 (2020): 146–162.

[304] L. F. Ye, K. R. Chaudhary, F. Zandkarimi, et al., “Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes With Ferroptosis Inducers,” Acs Chemical Biology 15, no. 2 (2020): 469–484.

[305] K. K. Saini, P. Chaturvedi, A. Sinha, et al., “Loss of PERK Function Promotes Ferroptosis by Downregulating SLC7A11 (System Xc−) in Colorectal Cancer,” Redox Biology 65 (2023): 102833.

[306] L. Feng, K. Zhao, L. Sun, et al., “SLC7A11 Regulated by NRF2 Modulates Esophageal Squamous Cell Carcinoma Radiosensitivity by Inhibiting Ferroptosis,” Journal of Translational Medicine 19, no. 1 (2021): 367.

[307] Q. Xu, X. Wen, C. Huang, et al., “RRFERV Stabilizes TEAD1 Expression to Mediate Nasopharyngeal Cancer Radiation Resistance Rendering Tumor Cells Vulnerable to Ferroptosis,” International Journal of Surgery 111, no. 1 (2025): 450–466.

[308] Q. Chen, W. Zheng, J. Guan, et al., “SOCS2-Enhanced Ubiquitination of SLC7A11 Promotes Ferroptosis and Radiosensitization in Hepatocellular Carcinoma,” Cell Death and Differentiation 30, no. 1 (2023): 137–151.

[309] P. Koppula, G. Lei, Y. Zhang, et al., “A Targetable CoQ-FSP1 Axis Drives Ferroptosis- and Radiation-Resistance in KEAP1 Inactive Lung Cancers,” Nature Communications 13, no. 1 (2022): 2206.

[310] G. Yang, B. Qian, L. He, et al., “Application Prospects of Ferroptosis in Colorectal Cancer,” Cancer Cell International 25, no. 1 (2025): 59.

[311] P. Kong, M. Yang, Y. Wang, K. N. Yu, L. Wu, and W. Han, “Ferroptosis Triggered by STAT1- IRF1-ACSL4 Pathway Was Involved in Radiation-Induced Intestinal Injury,” Redox Biology 66 (2023): 102857.

[312] L. An, M. Li, and Q. Jia, “Mechanisms of Radiotherapy Resistance and Radiosensitization Strategies for Esophageal Squamous Cell Carcinoma,” Molecular Cancer 22, no. 1 (2023): 140.

[313] L. H. Butterfield and Y. G. Najjar, “Immunotherapy Combination Approaches: Mechanisms, Biomarkers and Clinical Observations,” Nature Reviews Immunology 24, no. 6 (2024): 399–416.

[314] J. S. Kim and A. R. Chang, “Abscopal Effect in Metastatic Breast Cancer Treated With Stereotactic Body Radiotherapy in the Absence of Immunotherapy,” Frontiers in Oncology 13 (2023): 1243053.

[315] O. Piercey, J. M. Tomaszewski, and K. Smith, “Intracranial Response After Extracranial Radiation in a Patient With Rapidly Progressing Metastatic Melanoma,” BMJ Case Reports 14, no. 6 (2021): e240921.

[316] M. P. MacManus, M. S. Hofman, R. J. Hicks, et al., “Abscopal Regressions of Lymphoma after Involved-Site Radiation Therapy Confirmed by Positron Emission Tomography,” International Journal of Radiation and Oncology in Biology and Physics 108, no. 1 (2020): 204–211.

[317] M. A. D'Andrea and G. K. Reddy, “Immune System Activation in Patients with Metastatic Renal Cell Carcinoma Induced by the Systemic Abscopal Effects of Radiation Therapy,” Oncology Research and Treatment 46 (2023): 33–44, https://pubmed.ncbi.nlm.nih.gov/36349774/.

[318] E. B. Golden, A. Chhabra, A. Chachoua, et al., “Local Radiotherapy and Granulocyte-Macrophage Colony-Stimulating Factor to Generate Abscopal Responses in Patients With Metastatic Solid Tumours: A Proof-of-Principle Trial,” Lancet Oncology 16, no. 7 (2015): 795–803.

[319] D. J. Craig, N. S. Nanavaty, M. Devanaboyina, et al., “The Abscopal Effect of Radiation Therapy,” Future Oncology 17, no. 13 (2021): 1683–1694.

[320] B. Wu, B. Zhang, B. Li, H. Wu, and M. Jiang, “Cold and Hot Tumors: From Molecular Mechanisms to Targeted Therapy,” Signal Transduct Target Ther 9, no. 1 (2024): 274.

[321] S. Demaria and S. C. Formenti, “Radiotherapy Effects on Anti-Tumor Immunity: Implications for Cancer Treatment,” Frontiers in Oncology 3 (2013): 128.

[322] H. E. Barker, J. T. E. Paget, A. A. Khan, and K. J. Harrington, “The Tumour Microenvironment After Radiotherapy: Mechanisms of Resistance and Recurrence,” Nature Reviews Cancer 15, no. 7 (2015): 409–425.

[323] S. W. Linderman, L. DeRidder, L. Sanjurjo et al., “Enhancing Immunotherapy With Tumour-Responsive Nanomaterials,” Nature Reviews Clinical Oncology 22 (2025): 262–282, https://pubmed.ncbi.nlm.nih.gov/40050505/.

[324] S. Bonvalot, P. L. Rutkowski, J. Thariat, et al., “Final Safety and Health-Related Quality of Life Results of the Phase 2/3 Act.In.Sarc Study with Preoperative NBTXR3 Plus Radiation Therapy Versus Radiation Therapy in Locally Advanced Soft-Tissue Sarcoma,” International Journal of Radiation and Oncology in Biology and Physics 114, no. 3 (2022): 422–432.

[325] V. K. Dhiman, M. J. Bolt, and K. P. White, “Nuclear Receptors in Cancer—Uncovering New and Evolving Roles Through Genomic Analysis,” Nature Reviews Genetics 19, no. 3 (2018): 160–174.

[326] R. Santos, O. Ursu, A. Gaulton, et al., “A Comprehensive Map of Molecular Drug Targets,” Nature Reviews Drug Discovery 16, no. 1 (2017): 19–34.

[327] M. D. Long and M. J. Campbell, “Pan-Cancer Analyses of the Nuclear Receptor Superfamily,” Nuclear Receptor Research 2 (2015): 101182.

[328] Z. Yang, R. C. Gimple, N. Zhou, L. Zhao, J. Å. Gustafsson, and S. Zhou, “Targeting Nuclear Receptors for Cancer Therapy: Premises, Promises, and Challenges,” Trends in Cancer 7, no. 6 (2021): 541–556.

[329] K. J. Winzer, W. Sauerbrei, M. Braun, et al., “Radiation Therapy and Tamoxifen After Breast-Conserving Surgery: Updated Results of a 2 X 2 Randomised Clinical Trial in Patients With Low Risk of Recurrence,” European Journal of Cancer 46, no. 1 (2010): 95–101.

[330] P. Mulvenna, M. Nankivell, R. Barton, et al., “Dexamethasone and Supportive Care With or Without Whole Brain Radiotherapy in Treating Patients With Non-Small Cell Lung Cancer With Brain Metastases Unsuitable for Resection or Stereotactic Radiotherapy (QUARTZ): Results From a Phase 3, Non-Inferiority, Randomised Trial,” Lancet 388, no. 10055 (2016): 2004–2014.

[331] I. Kaplan, G. J. Bubley, R. S. Bhatt, et al., “Enzalutamide with Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 Study,” International Journal of Radiation and Oncology in Biology and Physics 110, no. 5 (2021): 1416–1422.

[332] U. De Giorgi, S. J. Freedland, A. Rannikko, et al., “Enzalutamide in Patients With High-Risk Biochemically Recurrent Prostate Cancer According to the European Association of Urology Definition: A Post Hoc Analysis of EMBARK,” Prostate Cancer Prostatic Dis Published Online March 26 (2025), https://doi.org/10.1038/s41391-025-00959-8.

[333] R. Tang, J. Yin, Y. Liu, and J. Xue, “FLASH Radiotherapy: A New Milestone in the Field of Cancer Radiotherapy,” Cancer Letters 587 (2024): 216651.

[334] H. S. Li, R. Tang, H. S. Shi, et al., “Ultra-High Dose Rate Radiotherapy Overcomes Radioresistance in Head and Neck Squamous Cell Carcinoma,” Signal Transduction and Targeted Therapy 10, no. 1 (2025): 82.

[335] J. Bourhis, W. J. Sozzi, P. G. Jorge et al., “Treatment of a First Patient with FLASH-Radiotherapy,” Radiotherapy and Oncology 139 (2019): 18–22., https://pubmed.ncbi.nlm.nih.gov/31303340/.

[336] A. E. Mascia, E. C. Daugherty, Y. Zhang, et al., “Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial,” JAMA Oncology 9, no. 1 (2023): 62–69.

[337] F. Geirnaert, L. Kerkhove, P. Montay-Gruel, T. Gevaert, I. Dufait, and M. De Ridder, “Exploring the Metabolic Impact of FLASH Radiotherapy,” Cancers 17, no. 1 (2025): 133.

[338] M. Provinciali, M. Cardelli, F. Marchegiani, and E. Pierpaoli, “Impact of Cellular Senescence in Aging and Cancer,” Current Pharmaceutical Design 19, no. 9 (2013): 1699–1709.

[339] A. R. Barr, S. Cooper, F. S. Heldt, et al., “DNA Damage During S-Phase Mediates the Proliferation-Quiescence Decision in the Subsequent G1 via P21 Expression,” Nature Communications 8, no. 1 (2017): 14728.

[340] L. Zhang, J. Ma, J. Zhang, et al., “Radiotherapy-Associated Cellular Senescence and EMT Alterations Contribute to Distinct Disease Relapse Patterns in Locally Advanced Cervical Cancer,” Advanced Science 12, no. 12 (2025): e2412574.

[341] L. Le Pelletier, M. Mantecon, J. Gorwood, et al., “Metformin Alleviates Stress-Induced Cellular Senescence of Aging Human Adipose Stromal Cells and the Ensuing Adipocyte Dysfunction,” Elife 10 (2021): e62635.

[342] S. Zhang, C. Wang, Y. Zhu, et al., “DNA-Capturing Manganese-Coordinated Chitosan Microparticles Potentiate Radiotherapy via Activating the cGAS-STING Pathway and Maintaining Tumor-Infiltrating CD8+ T-Cell Stemness,” Advanced Materials 37, no. 12 (2025): e2418583.

[343] Q. Li, Q. Chen, S. Xiao, et al., “A Salidroside-Based Radiosensitizer Regulates the Nrf2/ROS Pathway for X-Ray Activated Synergistic Cancer Precise Therapy,” Advanced Materials 37, no. 24 (2025): e2413226.

[344] Y. Jiang, H. Cao, H. Deng, et al., “Gold-siRNA Supraclusters Enhance the Anti-Tumor Immune Response of Stereotactic Ablative Radiotherapy at Primary and Metastatic Tumors,” Nature Biotechnology 43 (2024): 1496–1509.

[345] D. Wang, Y. Liao, H. Zeng, et al., “Manipulating Radiation-Sensitive Z-DNA Conformation for Enhanced Radiotherapy,” Advanced Materials (Deerfield Beach, Fla) 36, no. 29 (2024): e2313991.

[346] Y. Liao, D. Wang, C. Gu, et al., “A Cuproptosis Nanocapsule for Cancer Radiotherapy,” Nature Nanotechnology 19, no. 12 (2024): 1892–1902.

[347] L. Cao, Y. Yang, Y. Zheng, et al., “X-Ray-Triggered CO-Release From Gold Nanocluster: All-in-One Nanoplatforms for Cancer Targeted Gas and Radio Synergistic Therapy,” Advanced Materials 36, no. 25 (2024): e2401017.

[348] O. Michaeli, I. Luz, M. Vatarescu, et al., “APR-246 as a Radiosensitization Strategy for Mutant P53 Cancers Treated With Alpha-Particles-Based Radiotherapy,” Cell Death & Disease 15, no. 6 (2024): 426.

[349] F. Mudassar, P. Ing, S. Nguyen, et al., “DDDR-11. Inhibiting Oxidative Phosphorylation And Hypoxia With Atovaquone—A Strategy to Radiosensitize Diffuse Midline Glioma,” Neuro-Oncology 26 (2024) viii127–viii128, https://dx.doi.org/10.1093/neuonc/noae165.0496.

[350] W. Li, S. Zhang, L. Liu, et al., “Enhancing Chordoma Radiotherapy: Ta@PVP Nanoparticles as Potent Radiosensitizers,” ACS Applied Materials & Interfaces 17, no. 1 (2025): 750–762.

[351] J. D. Rondeau, S. Lipari, B. Mathieu, et al., “Mitochondria-Targeted Antioxidant MitoQ Radiosensitizes Tumors by Decreasing Mitochondrial Oxygen Consumption,” Cell Death Discovery 10, no. 1 (2024): 514.

[352] J. Chen, D. J. Laverty, S. Talele, et al., “Aberrant ATM Signaling and Homology-Directed DNA Repair as a Vulnerability of P53-Mutant GBM to AZD1390-Mediated Radiosensitization,” Science Translational Medicine 16, no. 734 (2024): eadj5962.

[353] H. Liu, Q. Wang, W. Lan, D. Liu, J. Huang, and J. Yao, “Radiosensitization Effect of Quinoline-Indole-Schiff Base Derivative 10E on Non-Small Cell Lung Cancer Cells in Vitro and in Tumor Xenografts,” Investigational New Drugs 42, no. 4 (2024): 405–417.

[354] M. Gallitto, X. Zhang, L. De, et al., “Targeted Delivery of Napabucasin With Radiotherapy Improves Outcomes in Diffuse Midline Glioma,” Neuro-Oncology 27, no. 3 (2025): 795–810.

[355] R. Chen, J. Gong, Z. Yu, et al., “X-Ray Triggered Bimetallic Nanoassemblies as Radiosensitizers and STING Agonists for a CDT/Radio-Immunotherapy Strategy,” Acta Biomaterialia 192 (2025): 366–376.

[356] J. Ji, S. Dragojevic, C. M. Callaghan, et al., “Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-Derived Melanoma Brain Metastasis Xenografts,” Molecular Cancer Therapeutics 23, no. 5 (2024): 662–671.

[357] Y. Yang, Y. Gu, M. Wu, et al., “Radiosensitizing Effects of Olaparib Nanoparticles Modified by Bifidobacterium Antibodies on Lung Cancer,” Reactive and Functional Polymers 217 (2025): 106464.

[358] T. Liu, C. Shi, L. Duan, et al., “A Highly Hemocompatible Erythrocyte Membrane-Coated Ultrasmall Selenium Nanosystem for Simultaneous Cancer Radiosensitization and Precise Antiangiogenesis,” Journal of Materials Chemistry B 6, no. 29 (2018): 4756–4764.

[359] I. Nuzzolese, S. Cavalieri, L. F. Licitra, and S. Alfieri, “The Role of Cetuximab in Non-Melanoma Skin Cancer: A Review of Clinical Evidence and Emerging Strategies,” Current Treatment Options in Oncology 26, no. 8 (2025): 673–687.

[360] X. Xiao, Y. Wang, J. Chen, et al., “Self-Targeting Platinum(IV) Amphiphilic Prodrug Nano-Assembly as Radiosensitizer for Synergistic and Safe Chemoradiotherapy of Hepatocellular Carcinoma,” Biomaterials 289 (2022): 121793.

[361] B. Tan, Y. Huang, B. Zhang, and N. Lin, “The Effect of Ibrutinib on Radiosensitivity in Pancreatic Cancer Cells by Targeting EGFR/AKT/mTOR Signaling Pathway,” Biomedicine & Pharmacotherapy 128 (2020): 110133.

[362] A. Boretti, “Evidence for the Use of Curcumin in Radioprotection and Radiosensitization,” Phytotherapy Research 38, no. 2 (2024): 464–469.

[363] M. Schwab and G. Multhoff, “A Low Membrane Hsp70 Expression in Tumor Cells with Impaired Lactate Metabolism Mediates Radiosensitization by NVP-AUY922,” Frontiers in Oncology 12 (2022): 861266.

[364] L. Bourillon, C. Bourgier, N. Gaborit, et al., “An Auristatin-Based Antibody-Drug Conjugate Targeting HER3 Enhances the Radiation Response in Pancreatic Cancer,” International Journal of Cancer 145, no. 7 (2019): 1838–1851.

[365] K. Tomoda, Y. T. Tam, H. Cho, D. Buehler, K. R. Kozak, and G. S. Kwon, “Triolimus: A Multi-Drug Loaded Polymeric Micelle Containing Paclitaxel, 17-AAG, and Rapamycin as a Novel Radiosensitizer,” Macromolecular Bioscience 17, no. 1 (2017),

[366] X. Wang, J. M. Gu, J. Meng, and C. L. Shao, “[The Radiosensitization of Nimotuzumab on CAL-27 Cells After 125I Seeds Irradiation],” Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology 25, no. 4 (2016): 409–413.

[367] Y. Xu, J. Lv, C. Kong, et al., “Introducing Urea Into Tirapazamine Derivatives to Enhance Anticancer Therapy,” National Science Review 11, no. 4 (2024): nwae038.

[368] U. Hennrich and M. Eder, “[177Lu]Lu-PSMA-617 (PluvictoTM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer,” Pharmaceuticals (Basel) 15, no. 10 (2022): 1292.

[369] L. Bodei, M. Cremonesi, M. Ferrari, et al., “Dosimetry of [177Lu]Lu-DOTATATE in Patients With Advanced Midgut Neuroendocrine Tumors: Results From a Substudy of the Phase III NETTER-1 Trial,” Journal of Nuclear Medicine 66, no. 3 (2025): 449–456.

[370] M. Durando, A. K. Gopal, J. Tuscano, and D. Persky, “A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for Lymphoma,” Oncologist 29, no. 4 (2024): 278–288.

[371] J. C. Chiang, Z. Shang, T. Rosales, et al., “Lipoylation Inhibition Enhances Radiation Control of Lung Cancer by Suppressing Homologous Recombination DNA Damage Repair,” Science Advances 11, no. 11 (2025): eadt1241.

[372] L. Qin, G. Tang, R. Gui, et al., “ATRX Loss Inhibits DDR to Strengthen Radio-Sensitization in P53-Deficent HCT116 Cells,” Scientific Reports 15, no. 1 (2025): 793.

[373] R. Moia, D. Talotta, L. Terzi Di Bergamo, et al., “Molecular Clustering on ctDNA Improves the Prognostic Stratification of Patients With DLBCL Compared With ctDNA Levels,” Blood Advances 9, no. 7 (2025): 1692–1701.

[374] A. S. Cottereau, S. Becker, F. Broussais, et al., “Prognostic Value of Baseline Total Metabolic Tumor Volume (TMTV0) Measured on FDG-PET/CT in Patients With Peripheral T-Cell Lymphoma (PTCL),” Annals of Oncology 27, no. 4 (2016): 719–724.

[375] L. Zhao, D. W. Chang, Y. Gong, C. Eng, and X. Wu, “Measurement of DNA Damage in Peripheral Blood by the γ-H2AX Assay as Predictor of Colorectal Cancer Risk,” DNA Repair 53 (2017): 24–30.

[376] B. Wang, Z. Zhang, S. Xia, M. Jiang, and Y. Wang, “Expression of γ-H2AX and Patient Prognosis in Breast Cancer Cohort,” Journal of Cellular Biochemistry 120, no. 8 (2019): 12958–12965.

[377] K. Xiao, Y. Lai, X. Liu, et al., “PERFUME: Detection of 8-Oxoguanine DNA Glycosylase Activity Based on Primer Exchange Reaction and Functionalized Hemin/G-Quadruplex DNAzyme,” Talanta Open 9 (2024): 100288.

[378] F. Zhan, X. Liu, H. Zhou, X. Wang, and X. Yao, “68 Ga-FAPI-04 Versus 18 F-FDG PET/CT in Duodenal Synovial Sarcoma,” Clinical Nuclear Medicine 50 (2025): 785–786.

[379] S. Ma, M. Zhou, Y. Xu, et al., “Clinical Application and Detection Techniques of Liquid Biopsy in Gastric Cancer,” Molecular Cancer 22, no. 1 (2023): 7.

[380] “Liquid Biopsy Technique May Allow Early Screening,” Cancer Discovery 7, no. 11(2017): 1207.

[381] N. Sano, H. Yoshino, Y. Sato, H. Honma, C. E. J. Cordonier, and I. Kashiwakura, “Ionizing Radiation Combined With Gold Complex Compounds Causes Apoptosis in Colorectal Cancer Cells by Increasing the Level of Caspase-3,” Current Molecular Medicine 25 (2025): 1395–1404.

[382] E. Moreno Roig, A. J. Groot, A. Yaromina, et al., “HIF-1α and HIF-2α Differently Regulate the Radiation Sensitivity of NSCLC Cells,” Cells 8, no. 1 (2019): 45.

[383] A. Salem, “Hypoxia-Targeted Dose Painting in Radiotherapy,” Seminars in Radiation Oncology 33, no. 3 (2023): 298–306.

[384] Y. Wu, Y. Song, R. Wang, and T. Wang, “Molecular Mechanisms of Tumor Resistance to Radiotherapy,” Molecular Cancer 22, no. 1 (2023): 96.

[385] H. Ni, Z. J. Reitman, W. Zou, et al., “FLASH Radiation Reprograms Lipid Metabolism and Macrophage Immunity and Sensitizes Medulloblastoma to CAR-T Cell Therapy,” Nature Cancer 6, no. 3 (2025): 460–473.

[386] M. Chaoui, O. Bouhali, and Y. Tayalati, “FLASH Radiotherapy: Technical Advances, Evidence of the FLASH Effect and Mechanistic Insights,” Biomedical Physics & Engineering Express 11, no. 2 (2025), https://doi.org/10.1088/2057-1976/adbcb1.

[387] V. Trappetti, J. Fazzari, C. Fernandez-Palomo, et al., “Targeted Accumulation of Macrophages Induced by Microbeam Irradiation in a Tissue-Dependent Manner,” Biomedicines 10, no. 4 (2022): 735.

[388] L. P. Taliaferro, A. L. DiCarlo, and M. M. Satyamitra, “NIH Policies and Regulatory Pathways for the Advancement of Radiation Medical Countermeasures and Biodosimetry Tools to U.S. FDA Licensure,” Radiation Research 197, no. 5 (2022), https://doi.org/10.1667/RADE-21-00206.1.

[389] D. R. Cassatt, A. L. DiCarlo, and O. Molinar-Inglis, “Product Development Within the National Institutes of Health Radiation and Nuclear Countermeasures Program,” Radiation Research 201, no. 5 (2024): 471–478.

[390] H. Hricak, M. E. Mayerhoefer, K. Herrmann, et al., “Advances and Challenges in Precision Imaging,” Lancet Oncology 26, no. 1 (2025): e34–e45.

[391] J. Xiang, X. Wang, X. Zhang, et al., “A Vision–Language Foundation Model for Precision Oncology,” Nature 638, no. 8051 (2025): 769–778.

[392] T. G. Chang, S. Park, A. A. Schäffer, P. Jiang, and E. Ruppin, “Hallmarks of Artificial Intelligence Contributions to Precision Oncology,” Nature Cancer 6, no. 3 (2025): 417–431.

[393] J. Luo and D. B. Solit, “Leveraging Real-World Data to Advance Biomarker Discovery and Precision Oncology,” Cancer Cell 43, no. 4 (2025): 606–610.

[394] C. Phuong, B. Qiu, S. Mueller, and S. E. Braunstein, “Precision Based Approach to Tailoring Radiotherapy in the Multidisciplinary Management of Pediatric Central Nervous System Tumors,” Journal of the National Cancer Center 3, no. 2 (2023): 141–149.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.